CSBR:NASDAQ
Champions Oncology Inc
$4.59
arrow_downward
-1.89%(-0.088) 1D
Nov 17, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.70
High
$4.70
Low
$4.59
Mkt. cap
63.91M
Avg. vol.
7.80K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.70
High
$4.70
Low
$4.59
Mkt. cap
63.91M
Avg. vol.
7.80K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
BeInCrypto
·
1 hour ago
How Deep Do S&P 500 Corrections Usually Go? Where 2026’s Drop Ranks
TradingView
·
1 hour ago
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus
The Motley Fool
·
1 hour ago
Vanguard S&P 500 ETF vs. Schwab U.S. Dividend ETF: How Much You’d Need to Collect $1,000 a Month From Each.
MarketWatch
·
2 hours ago
The S&P 500 just broke a crucial support level. Here’s what history shows may happen now.
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com